CCDC122 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.180200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.452000E-01
Normal-vs-Stage2
1.443000E-01
Normal-vs-Stage3
7.368000E-02
Normal-vs-Stage4
3.509200E-01
Stage1-vs-Stage2
1.215980E-01
Stage1-vs-Stage3
4.308300E-02
Stage1-vs-Stage4
4.685600E-01
Stage2-vs-Stage3
2.660000E-01
Stage2-vs-Stage4
5.537200E-01
Stage3-vs-Stage4
7.567900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.282000E-01
Normal-vs-AfricanAmerican
3.734300E-02
Normal-vs-Asian
3.941800E-01
Caucasian-vs-AfricanAmerican
2.682600E-01
Caucasian-vs-Asian
9.643000E-01
AfricanAmerican-vs-Asian
3.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.927600E-01
Normal-vs-Female
2.659000E-01
Male-vs-Female
7.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.016600E-01
Normal-vs-Age(41-60Yrs)
4.490000E-01
Normal-vs-Age(61-80Yrs)
1.216000E-01
Normal-vs-Age(81-100Yrs)
9.784500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.475000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.790050E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.903200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.033220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.953800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.002440E-01
Normal-vs-Daily Drinker
6.283800E-02
Normal-vs-Weekly Drinker
8.722000E-02
Normal-vs-Occasional Drinker
4.893200E-01
Normal-vs-Social Drinker
8.294000E-01
Non Drinker-vs-Daily Drinker
5.931600E-01
Non Drinker-vs-Weekly Drinker
7.026800E-01
Non Drinker-vs-Occasional Drinker
1.756390E-01
Non Drinker-vs-Social Drinker
1.505850E-01
Daily Drinker-vs-Weekly Drinker
9.381800E-01
Daily Drinker-vs-Occasional Drinker
9.677500E-02
Daily Drinker-vs-Social Drinker
9.424000E-02
Weekly Drinker-vs-Occasional Drinker
1.710200E-01
Weekly Drinker-vs-Social Drinker
1.159360E-01
Occasional Drinker-vs-Social Drinker
5.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.195450E-01
Normal-vs-Grade 2
2.840400E-02
Normal-vs-Grade 3
1.435830E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.339800E-01
Grade 1-vs-Grade 3
4.870000E-01
Grade 1-vs-Grade 4
1.195450E-01
Grade 2-vs-Grade 3
3.711200E-01
Grade 2-vs-Grade 4
2.840400E-02
Grade 3-vs-Grade 4
1.435830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.006790E-01
Normal-vs-NonDiabetic
2.576000E-01
Diabetic-vs-NonDiabetic
2.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.751370E-01
Normal-vs-NoPancreatitis
2.219400E-01
Pancreatitis-vs-NoPancreatitis
8.520600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.554800E-01
Normal-vs-N1
1.549560E-01
N0-vs-N1
4.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.921250E-01
Normal-vs-TP53-NonMutant
6.033600E-01
TP53-Mutant-vs-TP53-NonMutant
7.166100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
